Notified body wants balanced view of EU proposals for high-risk devices
This article was originally published in SRA
Executive Summary
When it comes to the regulation of medical devices in the EU, the way forward certainly does not lie in introducing market approval by a central government agency and by currently non-existing government agencies recognizing each other's work in a decentralized market approval mechanism.